Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers
PHASE1
This is a randomized, double-blind, three-arm, parallel-group, single-dose ...